<DOC>
	<DOCNO>NCT00308295</DOCNO>
	<brief_summary>The main goal study determine whether American Heart Association-recommended fish oil dose efficacious , safe , tolerable hemodialysis patient . The secondary objective test effect fish oil supplementation inflammatory cardiovascular marker .</brief_summary>
	<brief_title>A Pilot Study Fish Oil Supplementation Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>1 . Age &lt; 18 2 . Pregnant individual 3 . Fish oil omega3 supplementation past 6 month 4 . Fish , corn , soybean , gelatin , vanilla allergy 5 . Currently enrol dietary investigational drug study 6 . Life expectancy &lt; 3 month 7 . Ongoing active illness require hospitalization 8 . Malabsorption syndromes 9 . Chronic heparin coumadin anticoagulation ( ? ? ) 10 . Active bleeding issue</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>